Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Evolv Technologies Holdings, Inc.EVLV · Entity 5017 | Chief Revenue Officer | December 19, 2023 | December 21, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Evolv Technologies Holdings, Inc.
Report date December 19, 2023 · Filed December 21, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 38,832 |
Ending reported balance
After 2023-12-19 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-12-19 · Exercise / conversion · Acquired 30,000 · Balance 68,832 Row 2 · 2023-12-19 · Sale · Disposed 30,000 · Balance 38,832 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on March 15, 2023. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.42 · Expires 2031-01-10 | Direct | 845,540 |
Reported balance
After 2023-12-19 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-12-19 · Exercise / conversion · Disposed 30,000 · Balance 845,540 F2: The option vests and becomes exercisable as to 25% of the shares on October 1, 2021 and in 36 equal monthly installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on March 15, 2023.
F2: The option vests and becomes exercisable as to 25% of the shares on October 1, 2021 and in 36 equal monthly installments thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 19, 2023 Filed Dec 21, 2023 01:30 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001628280-23-042315 · wk-form4_1703122219.xml · derivative · entry 3 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 845,540 Underlying: Class A Common Stock · 30,000 shares Expires 2031-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the shares on October 1, 2021 and in 36 equal monthly installments thereafter. Read SEC document |
| December 19, 2023 Filed Dec 21, 2023 01:30 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 30,000 | $5.00 | $150,000.00 |
DisclosureSEC source: 0001628280-23-042315 · wk-form4_1703122219.xml · nonDerivative · entry 2 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,832 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on March 15, 2023. Read SEC document |
| December 19, 2023 Filed Dec 21, 2023 01:30 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 30,000 | $0.42 | $12,600.00 |
DisclosureSEC source: 0001628280-23-042315 · wk-form4_1703122219.xml · nonDerivative · entry 1 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,832 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 01:32 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001628280-23-041854 · wk-form4_1702949567.xml · derivative · entry 3 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 875,540 Underlying: Class A Common Stock · 10,000 shares Expires 2031-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the shares on October 1, 2021 and in 36 equal monthly installments thereafter. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 01:32 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 10,000 | $4.77 | $47,700.00 |
DisclosureSEC source: 0001628280-23-041854 · wk-form4_1702949567.xml · nonDerivative · entry 2 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,832 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on March 15, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.70 to $4.95. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 01:32 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 10,000 | $0.42 | $4,200.00 |
DisclosureSEC source: 0001628280-23-041854 · wk-form4_1702949567.xml · nonDerivative · entry 1 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 48,832 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2023 Filed Nov 16, 2023 22:57 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001628280-23-039366 · wk-form4_1700175462.xml · derivative · entry 3 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 885,540 Underlying: Class A Common Stock · 10,000 shares Expires 2031-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the shares on October 1, 2021 and in 36 equal monthly installments thereafter. Read SEC document |
| November 15, 2023 Filed Nov 16, 2023 22:57 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 10,000 | $4.04 | $40,400.00 |
DisclosureSEC source: 0001628280-23-039366 · wk-form4_1700175462.xml · nonDerivative · entry 2 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,832 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on March 15, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.91 to $4.17. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 15, 2023 Filed Nov 16, 2023 22:57 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 10,000 | $0.42 | $4,200.00 |
DisclosureSEC source: 0001628280-23-039366 · wk-form4_1700175462.xml · nonDerivative · entry 1 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 48,832 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 16, 2023 Filed Oct 18, 2023 20:26 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001628280-23-034591 · wk-form4_1697660785.xml · derivative · entry 3 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 895,540 Underlying: Class A Common Stock · 10,000 shares Expires 2031-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the shares on October 1, 2021 and in 36 equal monthly installments thereafter. Read SEC document |
| October 16, 2023 Filed Oct 18, 2023 20:26 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 10,000 | $3.80 | $38,000.00 |
DisclosureSEC source: 0001628280-23-034591 · wk-form4_1697660785.xml · nonDerivative · entry 2 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,832 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on March 15, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.72 to $3.85. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 16, 2023 Filed Oct 18, 2023 20:26 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 10,000 | $0.42 | $4,200.00 |
DisclosureSEC source: 0001628280-23-034591 · wk-form4_1697660785.xml · nonDerivative · entry 1 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 48,832 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2023 Filed Sep 18, 2023 22:13 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001628280-23-032489 · wk-form4_1695075228.xml · derivative · entry 3 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 905,540 Underlying: Class A Common Stock · 10,000 shares Expires 2031-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the shares on October 1, 2021 and in 36 equal monthly installments thereafter. Read SEC document |
| September 15, 2023 Filed Sep 18, 2023 22:13 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 10,000 | $5.78 | $57,800.00 |
DisclosureSEC source: 0001628280-23-032489 · wk-form4_1695075228.xml · nonDerivative · entry 2 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,832 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on March 15, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.71 to $5.86. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 15, 2023 Filed Sep 18, 2023 22:13 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 10,000 | $0.42 | $4,200.00 |
DisclosureSEC source: 0001628280-23-032489 · wk-form4_1695075228.xml · nonDerivative · entry 1 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 48,832 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 22:07 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001628280-23-031420 · wk-form4_1693951626.xml · derivative · entry 3 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 915,540 Underlying: Class A Common Stock · 10,000 shares Expires 2031-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the shares on October 1, 2021 and in 36 equal monthly installments thereafter. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 22:07 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 10,000 | $6.99 | $69,900.00 |
DisclosureSEC source: 0001628280-23-031420 · wk-form4_1693951626.xml · nonDerivative · entry 2 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,832 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on March 15, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.93 to $7.06. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 22:07 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 10,000 | $0.42 | $4,200.00 |
DisclosureSEC source: 0001628280-23-031420 · wk-form4_1693951626.xml · nonDerivative · entry 1 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 48,832 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2023 Filed Aug 16, 2023 21:27 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001628280-23-029692 · wk-form4_1692221261.xml · derivative · entry 3 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 925,540 Underlying: Class A Common Stock · 10,000 shares Expires 2031-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the shares on October 1, 2021 and in 36 equal monthly installments thereafter. Read SEC document |
| August 15, 2023 Filed Aug 16, 2023 21:27 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 10,000 | $7.72 | $77,200.00 |
DisclosureSEC source: 0001628280-23-029692 · wk-form4_1692221261.xml · nonDerivative · entry 2 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,832 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on March 15, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.63 to $7.90. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 15, 2023 Filed Aug 16, 2023 21:27 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 10,000 | $0.42 | $4,200.00 |
DisclosureSEC source: 0001628280-23-029692 · wk-form4_1692221261.xml · nonDerivative · entry 1 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 48,832 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2023 Filed Aug 3, 2023 12:48 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001628280-23-027040 · wk-form4_1691066880.xml · derivative · entry 3 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 935,540 Underlying: Class A Common Stock · 10,000 shares Expires 2031-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the shares on October 1, 2021 and in 36 equal monthly installments thereafter. Read SEC document |
| August 01, 2023 Filed Aug 3, 2023 12:48 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 10,000 | $6.44 | $64,400.00 |
DisclosureSEC source: 0001628280-23-027040 · wk-form4_1691066880.xml · nonDerivative · entry 2 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,832 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on March 15, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.40 to $6.52. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 01, 2023 Filed Aug 3, 2023 12:48 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 10,000 | $0.42 | $4,200.00 |
DisclosureSEC source: 0001628280-23-027040 · wk-form4_1691066880.xml · nonDerivative · entry 1 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 48,832 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 14, 2023 Filed Jul 17, 2023 20:39 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001628280-23-024996 · wk-form4_1689626343.xml · derivative · entry 3 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 945,540 Underlying: Class A Common Stock · 10,000 shares Expires 2031-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the shares on October 1, 2021 and in 36 equal monthly installments thereafter. Read SEC document |
| July 14, 2023 Filed Jul 17, 2023 20:39 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 10,000 | $6.04 | $60,400.00 |
DisclosureSEC source: 0001628280-23-024996 · wk-form4_1689626343.xml · nonDerivative · entry 2 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,832 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on March 15, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.98 to $6.12. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 14, 2023 Filed Jul 17, 2023 20:39 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 10,000 | $0.42 | $4,200.00 |
DisclosureSEC source: 0001628280-23-024996 · wk-form4_1689626343.xml · nonDerivative · entry 1 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 48,832 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 03, 2023 Filed Jul 5, 2023 20:14 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001628280-23-024242 · wk-form4_1688588034.xml · derivative · entry 3 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 955,540 Underlying: Class A Common Stock · 10,000 shares Expires 2031-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the shares on October 1, 2021 and in 36 equal monthly installments thereafter. Read SEC document |
| July 03, 2023 Filed Jul 5, 2023 20:14 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 10,000 | $5.97 | $59,700.00 |
DisclosureSEC source: 0001628280-23-024242 · wk-form4_1688588034.xml · nonDerivative · entry 2 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,832 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on March 15, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.92 to $6.00. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 03, 2023 Filed Jul 5, 2023 20:14 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 10,000 | $0.42 | $4,200.00 |
DisclosureSEC source: 0001628280-23-024242 · wk-form4_1688588034.xml · nonDerivative · entry 1 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 48,832 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2023 Filed Jun 15, 2023 20:39 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001628280-23-022267 · wk-form4_1686861549.xml · derivative · entry 6 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 965,540 Underlying: Class A Common Stock · 10,000 shares Expires 2031-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the shares on October 1, 2021 and in 36 equal monthly installments thereafter. Read SEC document |
| June 15, 2023 Filed Jun 15, 2023 20:39 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 10,000 | $6.17 | $61,700.00 |
DisclosureSEC source: 0001628280-23-022267 · wk-form4_1686861549.xml · nonDerivative · entry 4 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,832 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on March 15, 2023. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.02 to $6.29. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 15, 2023 Filed Jun 15, 2023 20:39 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 10,000 | $0.42 | $4,200.00 |
DisclosureSEC source: 0001628280-23-022267 · wk-form4_1686861549.xml · nonDerivative · entry 3 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 48,832 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 20:39 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001628280-23-022267 · wk-form4_1686861549.xml · derivative · entry 5 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 975,540 Underlying: Class A Common Stock · 10,000 shares Expires 2031-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the shares on October 1, 2021 and in 36 equal monthly installments thereafter. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 20:39 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 10,000 | $6.35 | $63,500.00 |
DisclosureSEC source: 0001628280-23-022267 · wk-form4_1686861549.xml · nonDerivative · entry 2 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,832 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on March 15, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.27 to $6.40. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 20:39 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 10,000 | $0.42 | $4,200.00 |
DisclosureSEC source: 0001628280-23-022267 · wk-form4_1686861549.xml · nonDerivative · entry 1 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 48,832 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 21:37 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | GrantStock Option (Right to Buy) · Derivative | 265,957 | $0.00 Strike: $3.12 | $0.00 |
DisclosureSEC source: 0001628280-23-006722 · wf-form4_167822504289107.xml · derivative · entry 2 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,957 Underlying: Class A Common Stock · 265,957 shares Expires 2033-03-02 F3 · derivative.exercise_date: The stock option vests and becomes exercisable as to one sixteenth of the underlying shares on June 1, 2023 and in 15 equal quarterly installments thereafter. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 21:37 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | GrantRestricted Stock Units · Derivative | 200,320 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-006722 · wf-form4_167822504289107.xml · derivative · entry 1 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,320 Underlying: Class A Common Stock · 200,320 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. F2 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on March 1, 2024. F1 · derivative.expiration_date: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 22:11 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 22,578 | $2.92 | $65,927.76 |
DisclosureSEC source: 0001628280-23-006328 · wf-form4_167788143159249.xml · nonDerivative · entry 2 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,832 F1 · shares: The sale reported in the Form 4 was effected solely with the intent to cover withholding taxes in connection with the vesting of RSUs. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 22:11 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionRestricted Stock Units · Derivative | 59,688 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-006328 · wf-form4_167788143159249.xml · derivative · entry 3 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,395 Underlying: Class A Common Stock · 59,688 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. F3 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on March 1, 2023. F2 · derivative.expiration_date: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 22:11 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 59,688 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-006328 · wf-form4_167788143159249.xml · nonDerivative · entry 1 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,410 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 05, 2023 Filed Jan 9, 2023 23:22 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 1,102 | $2.37 | $2,611.74 |
DisclosureSEC source: 0001628280-23-000775 · wf-form4_167330656362440.xml · nonDerivative · entry 1 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,398 F1 · shares: The sale reported in the Form 4 was effected solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported RSUs. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.37 to $2.40. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 01:29 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,355 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001628280-23-000363 · wf-form4_167288215634978.xml · derivative · entry 3 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 985,540 Underlying: Class A Common Stock · 4,355 shares Expires 2031-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the shares on October 1, 2021 and in 36 equal monthly installments thereafter. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 01:29 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 4,355 | $2.55 | $11,105.25 |
DisclosureSEC source: 0001628280-23-000363 · wf-form4_167288215634978.xml · nonDerivative · entry 2 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on March 17, 2022. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 01:29 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 4,355 | $0.42 | $1,829.10 |
DisclosureSEC source: 0001628280-23-000363 · wf-form4_167288215634978.xml · nonDerivative · entry 1 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,855 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 01, 2023 Filed Jan 5, 2023 01:27 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | GrantRestricted Stock Units · Derivative | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-000361 · wf-form4_167288201815239.xml · derivative · entry 2 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Class A Common Stock · 2,500 shares Expires not disclosed F1 · derivative.exercise_price: On March 31, 2022, the reporting person was granted 5,000 performance-based restricted stock units ("RSUs"). 50% of the performance-based RSUs vested on January 1, 2023 based on achieving an annual bookings goal for the fiscal year ended December 31, 2022. The remaining RSUs will vest on January 1, 2024, subject to the reporting person's continued employment through such vesting date. Each RSU represents a contingent right to receive one share of Class A Common Stock and has no expiration date. F1 · shares: On March 31, 2022, the reporting person was granted 5,000 performance-based restricted stock units ("RSUs"). 50% of the performance-based RSUs vested on January 1, 2023 based on achieving an annual bookings goal for the fiscal year ended December 31, 2022. The remaining RSUs will vest on January 1, 2024, subject to the reporting person's continued employment through such vesting date. Each RSU represents a contingent right to receive one share of Class A Common Stock and has no expiration date. F1 · derivative.exercise_date: On March 31, 2022, the reporting person was granted 5,000 performance-based restricted stock units ("RSUs"). 50% of the performance-based RSUs vested on January 1, 2023 based on achieving an annual bookings goal for the fiscal year ended December 31, 2022. The remaining RSUs will vest on January 1, 2024, subject to the reporting person's continued employment through such vesting date. Each RSU represents a contingent right to receive one share of Class A Common Stock and has no expiration date. F1 · derivative.expiration_date: On March 31, 2022, the reporting person was granted 5,000 performance-based restricted stock units ("RSUs"). 50% of the performance-based RSUs vested on January 1, 2023 based on achieving an annual bookings goal for the fiscal year ended December 31, 2022. The remaining RSUs will vest on January 1, 2024, subject to the reporting person's continued employment through such vesting date. Each RSU represents a contingent right to receive one share of Class A Common Stock and has no expiration date. Read SEC document |
| January 01, 2023 Filed Jan 5, 2023 01:27 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | GrantClass A Common Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-000361 · wf-form4_167288201815239.xml · nonDerivative · entry 1 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 F1 · shares: On March 31, 2022, the reporting person was granted 5,000 performance-based restricted stock units ("RSUs"). 50% of the performance-based RSUs vested on January 1, 2023 based on achieving an annual bookings goal for the fiscal year ended December 31, 2022. The remaining RSUs will vest on January 1, 2024, subject to the reporting person's continued employment through such vesting date. Each RSU represents a contingent right to receive one share of Class A Common Stock and has no expiration date. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 12:18 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001628280-22-032145 · wf-form4_167145230023751.xml · derivative · entry 3 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 989,895 Underlying: Class A Common Stock · 10,000 shares Expires 2031-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the shares on October 1, 2021 and in 36 equal monthly installments thereafter. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 12:18 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 10,000 | $3.04 | $30,411.00 |
DisclosureSEC source: 0001628280-22-032145 · wf-form4_167145230023751.xml · nonDerivative · entry 2 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on March 17, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.98 to $3.09. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 12:18 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 10,000 | $0.42 | $4,200.00 |
DisclosureSEC source: 0001628280-22-032145 · wf-form4_167145230023751.xml · nonDerivative · entry 1 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.